Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Sara Sabbagh DO

Sara Sabbagh DO profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Rheumatology

image of /images/ORCIDiD_icon16x16.png   https://orcid.org/0000-0003-3176-9958


I am willing to collaborate on research projects.
I am willing to be a peer mentor.


Publications (16)

  • Recent Advances in Juvenile Dermatomyositis: Moving toward Integration of Myositis-Specific Antibody Clinical Phenotypes, IFN-Driven Pathogenesis, and Targeted Therapies. (Chen KL, Chiu YE, Vleugels RA, Co DO, Kim H, Sabbagh SE, Arkin LM) J Invest Dermatol 2024 Nov 11 PMID: 39530954 SCOPUS ID: 2-s2.0-85208676459 11/13/2024    
  • Corrigendum: Patients with juvenile idiopathic arthritis have decreased clonal diversity in the CD8+ T cell repertoire response to influenza vaccination. (Sabbagh SE, Haribhai D, Gershan JA, Verbsky J, Nocton J, Yassai M, Naumova EN, Hammelev E, Dasgupta M, Yan K, Gorski J, Williams CB) Front Immunol 2024;15:1446946 PMID: 38962010 PMCID: PMC11220386 SCOPUS ID: 2-s2.0-85197728513 07/04/2024    
  • Childhood Arthritis and Rheumatology Research Alliance Biologic Disease-Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis. (Tarvin SE, Sherman MA, Kim H, Balmuri N, Brown AG, Chow A, Gewanter HL, de Guzman MM, Huber AM, Kim S, Klein-Gitelman MS, Perron MM, Robinson AB, Sabbagh SE, Savani S, Shenoi S, Spitznagle J, Stingl C, Syverson G, Tory H, Spencer C, Childhood Arthritis and Rheumatology Research Alliance Juvenile Dermatomyositis Workgroup) Arthritis Care Res (Hoboken) 2024 Nov;76(11):1532-1539 PMID: 38937134 SCOPUS ID: 2-s2.0-85201290324 06/28/2024       2 Citations
  • Patients with juvenile idiopathic arthritis have decreased clonal diversity in the CD8+ T cell repertoire response to influenza vaccination. (Sabbagh SE, Haribhai D, Gershan JA, Verbsky J, Nocton J, Yassai M, Naumova EN, Hammelev E, Dasgupta M, Yan K, Gorski J, Williams CB) Front Immunol 2024;15:1306490 PMID: 38873594 PMCID: PMC11169902 SCOPUS ID: 2-s2.0-85195642328 06/14/2024       2 Citations
  • Integrating large language models in medicine: a study of Claude 2's performance in MDAAT scoring for idiopathic inflammatory myopathies. (Venerito V, Fornaro M, Sabbagh S, Ghosh S, Chinoy H, Gupta L, MyoLLM Investigators) Rheumatology (Oxford) 2024 Oct 01;63(10):e292-e293 PMID: 38648744 SCOPUS ID: 2-s2.0-85205524825 04/23/2024       2 Citations
  • Interferonopathies (Sabbagh SE, Verbsky JW) Nelson Textbook of Pediatrics: Volume 1-2 1 January 2024:1530-1535.e1 SCOPUS ID: 2-s2.0-85206224972 01/01/2024    
  • Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositis. (Karasawa R, Yudoh K, Sato T, Tanaka M, Sabbagh SE, Flegel WA, Mammen AL, Jarvis JN, Rider LG, Childhood Myositis Heterogeneity Study Group) Rheumatology (Oxford) 2023 Nov 02;62(11):3757-3762 PMID: 37144941 PMCID: PMC10629777 SCOPUS ID: 2-s2.0-85176496767 05/05/2023    
  • Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features. (Sherman MA, Graf R, Sabbagh SE, Galindo-Feria AS, Pinal-Fernandez I, Pak K, Kishi T, Flegel WA, Targoff IN, Miller FW, Lundberg IE, Rider LG, Mammen AL, Childhood Myositis Heterogeneity Collaborative Study Group) Rheumatology (Oxford) 2023 Feb 23;62(SI2):SI226-SI234 PMID: 35961028 PMCID: PMC9949705 SCOPUS ID: 2-s2.0-85160024916 08/13/2022       3 Citations
  • Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis. (Karasawa R, Yudoh K, Sato T, Tanaka M, Tamaki M, Sabbagh SE, O'Hanlon TP, Noroozi-Farhadi P, Targoff IN, Flegel WA, Mammen AL, Miller FW, Hicar MD, Rider LG, Jarvis JN) Rheumatology (Oxford) 2022 Jul 06;61(7):2969-2977 PMID: 34791087 PMCID: PMC9258543 SCOPUS ID: 2-s2.0-85134360741 11/19/2021       7 Citations
  • Anti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis. (Pinal-Fernandez I, Pak K, Gil-Vila A, Baucells A, Plotz B, Casal-Dominguez M, Derfoul A, Martinez-Carretero MA, Selva-O'Callaghan A, Sabbagh S, Casciola-Rosen L, Albayda J, Paik J, Tiniakou E, Danoff SK, Lloyd TE, Miller FW, Rider LG, Christopher-Stine L, Mammen AL, Childhood Myositis Heterogeneity Collaborative Study Group) Arthritis Rheumatol 2022 Feb;74(2):358-364 PMID: 34313394 PMCID: PMC8792092 SCOPUS ID: 2-s2.0-85119296457 07/28/2021       8 Citations
  • Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis. (Sabbagh SE, Pinal-Fernandez I, Casal-Dominguez M, Albayda J, Paik JJ, Miller FW, Rider LG, Mammen AL, Christopher-Stine L, Johns Hopkins Myositis Center Group) Clin Rheumatol 2021 Oct;40(10):4095-4100 PMID: 33851273 PMCID: PMC8463345 SCOPUS ID: 2-s2.0-85104360170 04/15/2021       19 Citations
  • Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America. (Sabbagh SE, Neely J, Chow A, DeGuzman M, Lai J, Lvovich S, McGrath T, Pereira M, Pinal-Fernandez I, Roberts J, Rouster-Stevens K, Schmeling H, Sura A, Tarshish G, Tucker L, Rider LG, Kim S, CARRA JDM Workgroup and the Childhood Myositis Heterogeneity Study Group) Rheumatology (Oxford) 2021 Feb 01;60(2):829-836 PMID: 32889531 PMCID: PMC7850515 SCOPUS ID: 2-s2.0-85102212098 09/06/2020       17 Citations
  • Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib. (Sabbagh S, Almeida de Jesus A, Hwang S, Kuehn HS, Kim H, Jung L, Carrasco R, Rosenzweig S, Goldbach-Mansky R, Rider LG) Brain 2019 Nov 01;142(11):e59 PMID: 31603187 PMCID: PMC6821280 SCOPUS ID: 2-s2.0-85074310339 10/12/2019       67 Citations
  • Response to: 'Comment on: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh S et al' by Yang et al. (Sabbagh S, Pinal Fernandez I, Miller FW, Rider LG, Mammen AL) Ann Rheum Dis 2020 Aug;79(8):e97 PMID: 31208959 PMCID: PMC8466717 SCOPUS ID: 2-s2.0-85068622893 06/19/2019    
  • Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. (Sabbagh S, Pinal-Fernandez I, Kishi T, Targoff IN, Miller FW, Rider LG, Mammen AL, Childhood Myositis Heterogeneity Collaborative Study Group) Ann Rheum Dis 2019 Jul;78(7):988-995 PMID: 31018961 PMCID: PMC7570952 SCOPUS ID: 2-s2.0-85064943075 04/26/2019       123 Citations
  • Pediatric rheumatology: addressing the transition to adult-orientated health care. (Sabbagh S, Ronis T, White PH) Open Access Rheumatol 2018;10:83-95 PMID: 30013406 PMCID: PMC6037274 SCOPUS ID: 2-s2.0-85055562492 07/18/2018       29 Citations
  • Last update: 03/04/2025